National Academies Press: OpenBook
« Previous: 3 Recommendations for Medicare Clincal Trial Reimbursement
Suggested Citation:"References." Institute of Medicine. 2000. Extending Medicare Reimbursement in Clinical Trials. Washington, DC: The National Academies Press. doi: 10.17226/9742.
×

References

American Association of Health Plans. AAHP Board of Directors Agreement Between AAHP and NIH for Support of Clinical Trials. Dated December 11, 1998. [http://www.aahp.org/menus/index.cfm?CFID=84873&CFTOKEN=5124]

Ault, T., Director, Bureau of Policy Development, Health Care Financing Administration. 1996. Statement on Investigational Medical Devices, Committee on Governmental Affairs, Permanent Subcommittee on Investigations, U.S. Senate, February 14, 1996.


Barlow, W., S. Taplin, D. Seger, J. Beckord, L. Ichikawa. 1998. Medical Care Costs of Cancer Patients on Protocol . NCI Meeting, Bethesda, MD: July 7.

Bull, J. P. 1959. The historical development of clinical therapeutic trials. J Chronic Dis 10:218–48.


Cochrane Library Controlled Trials Register. 1999. In: The Cochrane Library [database on CD-ROM]. Oxford, England: Update Software, issue 2.


DeParle, N.-A.M., Administrator, Health Care Financing Administration. 1998. Statement on Health Technology Assessment, Labor and Human Resources Committee, Subcommittee on Public Health and Safety, U.S. Senate, March 12, 1998.

Department of Defense 1999. DoD/NCI agreement expands TRICARE benefit to include cancer prevention trials. DoD Worldwide web site. [tricare.osd.mil/main/news/art0706.html]

Department of Defense/National Cancer Institute. 1996. Interagency Agreement Between the Department of Defense and National Cancer Institute for Partnership in Clinical Trials for Cancer.

Department of Veterans Affairs. Worldwide web site, August 1999.

Department of Veterans Affairs/National Cancer Institute. 1997. Interagency Agreement Between the Department of Veterans Affairs and the National Cancer Institute for a Partnership in Clinical Trials for Cancer.

Dickersin, K., and Y.I. Min. 1993. Publication bias: The problem that won't go away. Ann N Y Acad Sci 703:135–46.

Dobson, A., and Sturm, E. 1999. Reimbursement of Routine Patient Care Costs in Clinical Trials. (Report to the Institute of Medicine Committee on Routine Patient Care

Suggested Citation:"References." Institute of Medicine. 2000. Extending Medicare Reimbursement in Clinical Trials. Washington, DC: The National Academies Press. doi: 10.17226/9742.
×

Costs in Clinical Trials for Medicare Beneficiaries.) The Lewin Group, Fairfax, Va., 1999.

Doll, R. 1982. Clinical trials: Retrospect and prospect. Star Med 1:337–44.

Evans, R. 1992. Public and private insurer designation of transplantation programs. Transplantation 53(5): 1041–6.


Fireman, B., L. Fehrenbacher, L. Gruskin, and T. Ray. 1998. The Cost of Care in Cancer Clinical Trials at Kaiser Permanente, Northern California. NCI Meeting, Bethesda MD: July 7.

Fisher, R. A. 1926. The arrangement of field experiments. J Ministry Agricult Gt Brit 33:503–13.

Fisher, R. A. 1935. The Design of Experiments. Edinburgh: Oliver and Boyd.


Hartwig, J. E. 1996. Medical Coverage of Investigational Devices. Testimony Before the Committee on Governmental Affairs, Permanent Subcommittee on Investigations, U.S. Senate, February 14, 1996.

Health Care Financing Administration/Food and Drug Administration. 1995. Interagency Agreement Between the Food and Drug Administration and the Health Care Financing Administration Regarding Medicare Coverage of Certain Investigational Medical Devices (IDE Memorandum D95-2). Photocopy.

Hennekens, C. H., and J. E. Buring. 1987. Epidemiology in Medicine . Boston: Little, Brown, and Co.

Holohan, T. V., and H. Handelsman. 1996. Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease. Health Technol Assess (Rocky) 10(Sept.): 1–30.


Lilienfeld, A.M. 1982. Ceteris paribus: The evolution of the clinical trial. Bull Hist Med 56: 1–18.


McCray, A. National Library of Medicine, NIH. 1999. Personal communication to H. Gelband.

Medical Research Council. 1948. Streptomycin treatment of pulmonary tuberculosis. BMJ 2:769–82.

Meinert, C. L. 1986. Clinical Trials: Design, Conduct, and Analysis . Oxford: Oxford University Press, pp. 3–10.


Newcomer, L. 1999. Medical Director, United Health Group, personal communication, August 1999.


O'Rourke, P. 1999. Office of the Director, NIH. Personal communication to Hellen Gelband.


Szymanski, J. 1999. Office of the Assistant Secretary of Defense (Health Affairs), personal communication, October 1999.


U.S. General Accounting Office. 1997. Cancer Clinical Trials: Medicare Reimbursement Denials (GAO/HEHS-98-15R). Washington, D.C.: GAO.

U.S. General Accounting Office. 1999. NIH Clinical Trials: Various Factors Affect Patient Participation (GAO/HEHS-99-182). Washington, D.C.: GAO.


Wagner, J. L., S. R. Alberts, J. A. Sloan, S. Cha, J. Killian, M. J. O'Connell et al. 1999. Incremental costs of enrolling cancer patients in clinical trials: A population-based study. J Natl Cancer Inst 91(10):847–53.


Zelen, M. 1993. Large simple trials. In Clinical Trials and Statistics: Proceedings of a Symposium. Washington, D.C.: National Academy Press.

Suggested Citation:"References." Institute of Medicine. 2000. Extending Medicare Reimbursement in Clinical Trials. Washington, DC: The National Academies Press. doi: 10.17226/9742.
×
Page 65
Suggested Citation:"References." Institute of Medicine. 2000. Extending Medicare Reimbursement in Clinical Trials. Washington, DC: The National Academies Press. doi: 10.17226/9742.
×
Page 66
Next: Appendix A: Glossary, Acronyms, and Abbreviations »
Extending Medicare Reimbursement in Clinical Trials Get This Book
×
Buy Paperback | $29.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Increasingly over the past five years, uncertainty about reimbursement for routine patient care has been suspected as contributing to problems enrolling people in clinical trials. Clinical trial investigators cannot guarantee that Medicare will pay for the care required, and they must disclose this uncertainty to potential participants during the informed consent process. Since Medicare does not routinely "preauthorize" care (as do many commercial insurers) the uncertainty cannot be dispelled in advance. Thus, patients considering whether to enter trials must assume that they may have to pay bills that Medicare rejects simply because they have enrolled in the trial.

This report recommends an explicit policy for reimbursement of routine patient care costs in clinical trials. It further recommends that HCFA provide additional support for selected clinical trials, and that the government support the establishment of a national clinical trials registry. These policies (1) should assure that beneficiaries would not be denied coverage merely because they have volunteered to participate in a clinical trial; and (2) would not impose excessive administrative burdens on HCFA, its fiscal intermediaries and carriers, or investigators, providers, or participants in clinical trials. Explicit rules would have the added benefit of increasing the uniformity of reimbursement decisions made by Medicare fiscal intermediaries and carriers in different parts of the country. Greater uniformity would, in turn, decrease the uncertainty about reimbursement when providers and patients embark on a clinical trial.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!